Moderna Combination COVID and Flu Vaccine Heads to Final Trials After Positive Results

Moderna's combination Covid and flu vaccine is moving to final stage trial in adults 50+ this year after positive mid-stage results.

Moderna aims to get regulatory approval for the combination shot in 2025.

The company believes combination vaccines will simplify protection against respiratory viruses that peak at same time.

The shot generated immune response similar to or better than current flu vaccines in trial.

Safety data was similar to stand-alone Covid vaccine, with no new concerns identified.